Mitchener Stephen 4
4 · Karyopharm Therapeutics Inc. · Filed Jun 3, 2021
Insider Transaction Report
Form 4
Mitchener Stephen
SVP, Chief Business Officer
Transactions
- Sale
Common Stock
2021-06-02$9.29/sh−528$4,905→ 2,472 total
Footnotes (1)
- [F1]This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person.